Skip to contentA
Azora Therapeutics, Inc. (DE)
A
AZRAzora Therapeutics, Inc. (DE) Released Aug 12, 2022, after the close
10-Q filed Aug 15, 2022, 46 days after period end · 0001213900-22-047638
Q2 2022 · 10-Q
Revenue—
Net Income-$3.85M-$3.85MN/M vs Q2 2021N/M vs Q1 2022 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Azora Therapeutics, Inc. (DE) · CIK 1513525 · Engraved from SEC EDGAR
-$3.96-$3.96N/M vs Q2 2021N/M vs Q1 2022 Operating Income-$3,243,810N/M Operating Cash Flowderived-$3,534,391N/M Filing lag
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end